TL;DR
This study uses quantitative and kinetic proteomics to reveal how different human Apolipoprotein E (ApoE) isoforms (E2, E3, E4) affect protein homeostasis in mouse brains. The findings show that ApoE4 disrupts mitochondrial function and proteasomal/autophagic pathways, while ApoE2 promotes more coordinated mitochondrial maintenance, suggesting isoform-specific impacts on neurodegenerative disease risk.
What Problem Does This Paper Address?
Apolipoprotein E (ApoE) is a key player in lipid transport, and its different human isoforms (E2, E3, E4) are strongly linked to the risk of neurodegenerative diseases like Alzheimer's. Specifically, ApoE4 increases risk, while ApoE2 is protective. However, the precise molecular mechanisms by which these isoforms exert their influence, particularly at the protein level and how they affect the dynamic balance of protein synthesis and degradation (proteostasis), remain unclear. This paper aims to bridge this gap by investigating how ApoE isoforms alter the brain's proteome and its regulatory mechanisms.
Methods
The researchers employed a sophisticated proteomic approach combining quantitative proteomics (measuring protein abundance) and kinetic proteomics (measuring protein turnover rates). They used metabolic labeling with deuterium (D2O) in transgenic mice expressing human ApoE isoforms. This allowed them to track the synthesis and degradation of thousands of proteins over time.
Key techniques included:
- Liquid Chromatography-Mass Spectrometry (LC-MS/MS) for identifying and quantifying proteins.
- A simplified kinetic model of proteostasis to analyze the interplay between protein abundance and turnover.
- Data-dependent acquisition (DDA) for quantitative proteomics and MS1-only acquisition for kinetic measurements.
- Bioinformatic analysis using software like Peaks Studio and Deuterater, along with tools like StringDB for ontology analysis.
Datasets
The study utilized data from 72 homozygous ApoE transgenic mice (24 each of ApoE2, ApoE3, and ApoE4), with an equal distribution of males and females. The data was collected at multiple time points (Day 0, Hour 6, Day 1, Day 4, Day 16, and Day 32) post-D2O administration. The raw proteomics data has been deposited in the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD044460.
Key Insights and Ideas
- Brain-specific effects: The impact of ApoE isoforms on proteostasis is significantly amplified in the brain compared to the liver, suggesting tissue-specific roles.
- Mitochondrial dysregulation by ApoE4: ApoE4 leads to a fragmented and uncoordinated regulation of mitochondrial components, impacting aerobic respiration through proteasomal and autophagic dysregulation. This suggests a "piecemeal" approach to mitochondrial maintenance.
- Coordinated mitochondrial maintenance by ApoE2: In contrast, ApoE2 promotes a more cohesive regulation of mitochondrial matrix and membrane proteins, indicating coordinated maintenance of the entire organelle.
- Endolysosomal pathway disruption by ApoE4: ApoE4 significantly alters endocytic and lysosomal pathways, leading to reduced protein synthesis and increased degradation in certain components, potentially contributing to lysosomal dysfunction.
- Enhanced lysosomal function with ApoE2: ApoE2 appears to streamline endolysosomal events, suggesting better control over these processes.
- Proteasome and mitochondrial interplay: The study highlights the interconnectedness of proteasome and mitochondrial function, suggesting that ApoE4's impact on one can exacerbate issues in the other, contributing to neurodegeneration.
Key Results
- 4,849 proteins identified in the mouse brain across the three ApoE isoforms.
- ~2700 ontologies analyzed for ApoE isoform-dependent changes in proteostasis.
- Significant Aabundance shifts observed in 284 ontologies for E2vsE3 and 287 ontologies for E4vsE3.
- ApoE4 showed disrupted mitochondrial membrane and matrix protein regulation, impacting aerobic respiration.
- ApoE2 demonstrated coordinated mitochondrial maintenance.
- ApoE4 led to reduced synthesis and increased degradation in endolysosomal pathways, while ApoE2 showed more streamlined regulation.
- ApoE4 also showed reduced proteasomal activity and synthesis of HSP70 proteins, suggesting impaired protein quality control.
Limitations and Future Work
- Transgenic model limitations: The study acknowledges that using a transgenic model has limitations and suggests future confirmation in ApoE knock-in mice and human studies.
- Global effect not supported: The data does not support a global ApoE effect across all tissues, likely due to the brain's limited apolipoprotein repertoire and the blood-brain barrier.
- Cell type specificity: The study averages across all cell types in the brain, and future work could focus on isolating single cell types to better understand cell-type-specific metabolic changes in response to ApoE isoforms.
- Further investigation: The authors aim to delve deeper into these discoveries and authenticate their hypothesis across various ApoE models.
Summary updated